As generic semaglutide competition starts to line up, Novo Nordisk launches a cheaper copy of its GLP-1 blockbuster for diabetes.
As generic semaglutide competition starts to line up, Novo Nordisk launches a cheaper copy of its GLP-1 blockbuster for diabetes.